Meghmani Organics Limited (NSE:MOL)
India
· Delayed Price · Currency is INR 48.07
-0.14 (-0.29%)
At close: Mar 6, 2026
Meghmani Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 22,531 | 20,797 | 15,663 | 25,526 | 24,985 | 16,367 | Upgrade
|
| Revenue Growth (YoY) | 16.36% | 32.78% | -38.64% | 2.17% | 52.66% | 16.98% | Upgrade
|
| Cost of Revenue | 13,603 | 12,878 | 10,450 | 15,358 | 14,754 | 9,193 | Upgrade
|
| Gross Profit | 8,927 | 7,920 | 5,213 | 10,168 | 10,231 | 7,174 | Upgrade
|
| Selling, General & Admin | 1,345 | 1,157 | 1,169 | 1,308 | 1,208 | 1,030 | Upgrade
|
| Other Operating Expenses | 5,345 | 5,320 | 4,236 | 5,445 | 5,230 | 3,311 | Upgrade
|
| Operating Expenses | 7,881 | 7,558 | 6,328 | 7,523 | 7,065 | 4,848 | Upgrade
|
| Operating Income | 1,046 | 361.2 | -1,116 | 2,645 | 3,166 | 2,326 | Upgrade
|
| Interest Expense | -865.14 | -648.26 | -456.31 | -417.16 | -69.27 | -87.06 | Upgrade
|
| Interest & Investment Income | 42.42 | 42.42 | 118.31 | 175.74 | 177.81 | 26.48 | Upgrade
|
| Currency Exchange Gain (Loss) | 355.63 | 355.63 | 207.03 | 761.08 | 449.78 | 67.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 254.12 | -37.68 | 12.78 | -235.17 | -21.6 | -17.71 | Upgrade
|
| EBT Excluding Unusual Items | 833.05 | 73.31 | -1,234 | 2,929 | 3,703 | 2,315 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.56 | 1.56 | 21.85 | 9.45 | 124.41 | 130.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -15.09 | -15.09 | -9.42 | -5.25 | -7.42 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -8.1 | Upgrade
|
| Other Unusual Items | 34.93 | 34.93 | 9.55 | 197.3 | 207.18 | 15.81 | Upgrade
|
| Pretax Income | 854.44 | 94.7 | -1,212 | 3,131 | 4,088 | 2,518 | Upgrade
|
| Income Tax Expense | 449.19 | 200.71 | -151.52 | 753.77 | 1,044 | 653.22 | Upgrade
|
| Earnings From Continuing Operations | 405.26 | -106.01 | -1,060 | 2,377 | 3,044 | 1,865 | Upgrade
|
| Net Income | 405.26 | -106.01 | -1,060 | 2,377 | 3,044 | 1,865 | Upgrade
|
| Net Income to Common | 405.26 | -106.01 | -1,060 | 2,377 | 3,044 | 1,865 | Upgrade
|
| Net Income Growth | - | - | - | -21.92% | 63.25% | -37.66% | Upgrade
|
| Shares Outstanding (Basic) | 256 | 254 | 254 | 254 | 254 | 254 | Upgrade
|
| Shares Outstanding (Diluted) | 256 | 254 | 254 | 254 | 254 | 254 | Upgrade
|
| Shares Change (YoY) | 0.95% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 1.58 | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 | Upgrade
|
| EPS (Diluted) | 1.58 | -0.42 | -4.17 | 9.35 | 11.97 | 7.33 | Upgrade
|
| EPS Growth | - | - | - | -21.92% | 63.25% | -37.66% | Upgrade
|
| Free Cash Flow | - | -226.88 | -165.29 | -2,607 | -1,787 | 1,240 | Upgrade
|
| Free Cash Flow Per Share | - | -0.89 | -0.65 | -10.25 | -7.03 | 4.88 | Upgrade
|
| Dividend Per Share | - | - | - | 1.400 | 1.400 | 1.400 | Upgrade
|
| Gross Margin | 39.62% | 38.08% | 33.28% | 39.83% | 40.95% | 43.83% | Upgrade
|
| Operating Margin | 4.64% | 1.74% | -7.12% | 10.36% | 12.67% | 14.21% | Upgrade
|
| Profit Margin | 1.80% | -0.51% | -6.77% | 9.31% | 12.18% | 11.39% | Upgrade
|
| Free Cash Flow Margin | - | -1.09% | -1.05% | -10.21% | -7.15% | 7.58% | Upgrade
|
| EBITDA | 2,220 | 1,416 | -220.44 | 3,388 | 3,771 | 2,814 | Upgrade
|
| EBITDA Margin | 9.85% | 6.81% | -1.41% | 13.27% | 15.09% | 17.19% | Upgrade
|
| D&A For EBITDA | 1,174 | 1,055 | 895.13 | 742.94 | 604.78 | 487.85 | Upgrade
|
| EBIT | 1,046 | 361.2 | -1,116 | 2,645 | 3,166 | 2,326 | Upgrade
|
| EBIT Margin | 4.64% | 1.74% | -7.12% | 10.36% | 12.67% | 14.21% | Upgrade
|
| Effective Tax Rate | 52.57% | 211.94% | - | 24.08% | 25.53% | 25.94% | Upgrade
|
| Revenue as Reported | 23,261 | 21,236 | 16,040 | 26,487 | 25,947 | 16,614 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.